| 货号 | 0931/100 |
| 别名 | 4-[4-(4-Chlorophenyl)-4-hydroxy-1-p |
| 是否允许进口 | 否 |
| 是否危险品 | 是 |
| 供应商 | Tocris |
| 生物活性 | Dopamine antagonist with selectivity for D2-like receptors (Ki values are 1.2, ~ 7, 2.3, ~ 80 and ~ 100 nM for D2, D3, D4, D1 and D5 receptors respectively). Subtype-selective NMDA antagonist. |
| 运输条件 | Blue Ice |
| 存放说明 | Ambient |
| 纯度 | >99 % |
| 计算分子量 | 412.33 |
| 分子式 | C21H23ClFNO2.HCl |
| 可溶性/溶解性 | Soluble to 10 mM in ethanol with gentle warming and to 25 mM in DMSO with gentle warming |
| 参考文献 | IIyinet al (1996) Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol. Mol.Pharmacol. 50 1541. PMID: 8967976. Lynch and Gallagher (1996) Inhibition of N-methyl-D-aspartate receptors by haloperidol: development and pharmacological characterization in native and recombinant receptors. J.Pharmacol.Exp.Ther. 279 154. PMID: 8858988. Seeman and Van Tol (1994) Dopamine receptor pharmacology. TiPS 15 264. PMID: 7940991. Beresford and Ward (1987) Haloperidol decanoate. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in psychosis. Drugs 33 31. PMID: 3545764. Merck Index 124629. |